What type of study is this?

October 11, 2025Frontiers in ImmunologyOpen Access

Salvage sequential integrated boost radiotherapy followed by sintilimab–bevacizumab in cervical small-cell carcinoma with >10 brain metastases: A 3-year survivor case report

View Full Paper

Ask AI

Bookmark

The patient achieved complete remission and survived for three years after developing 16 brain metastases.
Combining whole-brain radiotherapy with sequential integrated boost radiotherapy improved treatment outcomes for cervical small cell carcinoma.
Immunotherapy and antiangiogenic therapy provided significant efficacy against brain metastases recurrence.
This case supports further investigation into multimodal approaches for managing aggressive cervical small cell carcinoma.

No takes yet. Share an insight, caveat, or question.

Case report shows 3-year survival in a patient with cervical small cell carcinoma and brain metastases, suggesting effective multimodal strategies.

Xu et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Case report shows 3-year survival in a patient with cervical small cell carcinoma and brain metastases, suggesting effective multimodal strategies.